Continued progress enrolling in its VMT-α-NET and VMT01 clinical trialsDisclosed a new internally discovered molecule that targets fibroblast ...

MINISO Group Holding Limited (NYSE:MNSO) is among the stocks that will 10x in 5 years according to analysts, along with ...

Q1 2024 Earnings Call Transcript May 11, 2024 Seres Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge ...

Cartesian Therapeutics, Inc. (NASDAQ: RNAC) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in ...

Oppenheimer raised the price target for the Viking Therapeutics Inc (NASDAQ:VKTX) stock to “an Outperform”. The rating was released on March 26, 2024, according to finviz. The research report from ...

Guggenheim raised the price target for the Travere Therapeutics Inc (NASDAQ:TVTX) stock from “a Buy” to “a Neutral”. The rating was released on March 27, 2024, according to finviz. We previously noted ...

Novartis is shelling out $1 billion upfront to buy a Watertown startup that's working to make radiation treatment more ...

Beam Therapeutics Inc. (BEAM) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended March 2024. This widely-known consensus ...

SEATTLE, May 03, 2024 (GLOBE NEWSWIRE) -- (“Perspective” or “the Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced treatment applications for cancers ...

Manmeet Soni; Chief Operating Officer, Chief Financial Officer; Summit Therapeutics Inc ...

Founder, Director; Corcept Therapeutics Inc Sean Maduck; President - Corcept Endocrinology; Corcept Therapeutics Inc William Guyer; Chief Development Officer; Corcept Therapeutics Inc Matt Kaplan; ...

Reshma Rangwala; Chief Medical Officer & Head of Research; Karyopharm Therapeutics Inc Sohanya Cheng; Executive Vice President, Chief Commercial Officer; Karyopharm Therapeutics Inc Mike Mano; Senior ...